•  
  •  
  •  
  •  

2025-07-18 12:18:16

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • ABM Knowledgeware Ltd Q1 FY2025-26 consolidated profit up marginally at Rs. 3.73 crore
  • CEAT Ltd reports QoQ increase in Q1FY26 consolidated PAT to Rs. 112.45 crores
  • National Standard India Ltd Q1FY26 profit down at Rs. 98.68 lakhs
  • Tata Communications Ltd consolidated Q1 FY2025-26 consolidated PAT slides to Rs. 189.98 crores
  • Nuvoco Vistas Corporation Ltd posts Rs. 133.16 crores consolidated PAT in Q1FY26

Keywords Selected:  IndocoRemedies

Research

  • Indoco Remedies - Q4FY22 Result Update - In-line quarter; strong revenue guidance for US & EU mkt - Upgrade to 'BUY'

Stock Report

  • Indoco Remedies Ltd announces the first day launch of Ticagrelor filmcoated tablets through its subsidiary in the United Kingdom
  • Indoco Remedies receives final approval from the USFDA for Allopurinol Tablets USP 200 mg
  • Indoco's Clinical Research Organisation - AnaCipher completes US FDA inspection
  • Indoco Remedies Ltd consolidated Q3FY25 loss widens to Rs. 26.39 crores
  • Indoco Remedies Limited receives warning letter from USFDA for Goa plants
  • Indoco announces strategic distribution partnership with Clarity Pharma, UK
  • Indoco Remedies Ltd Q2FY25 consolidated loss at Rs. 9.57 crores
  • Indoco Remedies Ltd receives OAI status from USFDA for Goa Plant 2 & 3
  • Indoco Remedies receives final ANDA approval from the USFDA for Cetirizine Hydrochloride Tablets USP, 10 mg OTC
  • Indoco Remedies receives USFDA final ANDA approval for Lofexidine Tablets 0.18 mg with Competitive Generic Therapy designation
  • Indoco Remedies Ltd gets 7 observations from USFDA for Plant 2 and 3 at Goa
  • Indoco Remedies Ltd Q1 FY25 consolidated PAT slumps to Rs. 2.62 crores
  • Indoco Remedies receives tentative ANDA approval from USFDA for Canagliflozin and Metformin Hydrochloride Tablets
  • Warren Remedies Pvt Ltd commences commercial production of Pharmaceutical Intermediates
  • Indoco Remedies Limited approves land purchase
  • Warren Remedies Pvt Ltd, a Wholly Owned Subsidiary of Indoco Remedies Ltd commences commercial production of Oral Care Products
  • Indoco Remedies Ltd posts decline in consolidated Q3 FY24 PAT to Rs. 16.30 crores
  • Indoco Remedies Ltd receives EIR from USFDA for Goa Plant-I
  • Indoco Remedies receives tentative ANDA approval from USFDA for Canagliflozin Tablets
  • Indoco Remedies Ltd consolidated Q2FY24 PAT up QoQ at Rs. 35.08 crores
  • Indoco's Baddi facility - Unit I receives GMP certification from EU Health Authority
  • Indoco Remedies Ltd Q1 FY24 consolidated PAT slides to Rs. 24.39 crores
  • Indoco's Goa facility - Plant III receives EU GMP certification from the German Health Authority
  • Indoco's Baddi facility receives EUGMP certification from Health Authority of Germany

Latest Post

  • ABM Knowledgeware Ltd Q1 FY2025-26 consolidated profit up marginally at Rs. 3.73 crore
  • CEAT Ltd reports QoQ increase in Q1FY26 consolidated PAT to Rs. 112.45 crores
  • National Standard India Ltd Q1FY26 profit down at Rs. 98.68 lakhs
  • Tata Communications Ltd consolidated Q1 FY2025-26 consolidated PAT slides to Rs. 189.98 crores
  • Nuvoco Vistas Corporation Ltd posts Rs. 133.16 crores consolidated PAT in Q1FY26


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024